BIO-key Partners with VaporVM to Expand Reach of its Advanced Identity and Access Management and Biometric Cybersecurity Solutions in Middle East and Africa
Rhea-AI Summary
BIO-key (NASDAQ: BKYI) announced a strategic partnership with Dubai-headquartered VaporVM on November 12, 2025 to expand distribution of BIO-key’s identity and biometric solutions across the Middle East and Africa. VaporVM will integrate and promote BIO-key’s PortalGuard IAM platform, Passkey:YOU (FIDO2 passwordless), PIN:You, WEB-key biometric engine, identity-bound biometrics, and certified scanners, and provide local deployment, partner enablement, and technical support. The collaboration targets enterprises and public-sector organizations operating on AWS, Azure, and GCP, aiming to combine VaporVM’s regional cloud and managed-services presence with BIO-key’s authentication technology to support secure, compliant digital transformation.
Positive
- Partnership executed on Nov 12, 2025
- Distribution extended across Middle East and Africa
- VaporVM to integrate BIO-key on AWS, Azure, and GCP
Negative
- None.
News Market Reaction 26 Alerts
On the day this news was published, BKYI gained 11.31%, reflecting a significant positive market reaction. Argus tracked a peak move of +27.6% during that session. Our momentum scanner triggered 26 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $767K to the company's valuation, bringing the market cap to $8M at that time.
Data tracked by StockTitan Argus on the day of publication.
DUBAI, United Arab Emirates and HOLMDEL, N.J., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a leading provider of Identity and Access Management (IAM) and biometric authentication solutions, has executed a strategic partnership with VaporVM, a global leader in cloud, cybersecurity, and managed services headquartered in Dubai, U.A.E.
This collaboration expands the potential for BIO-key to deliver its robust identity, authentication, and access management solutions to enterprises, public sector organizations, and institutions across the Middle East and Africa. The partnership combines VaporVM’s cloud-native expertise, regional presence and customer base with BIO-key’s award-winning PortalGuard® IAM platform, to deliver secure, seamless, and compliant digital transformation solutions for organizations operating across AWS, Azure, and Google Cloud Platform (GCP).
VaporVM will integrate and promote BIO-key’s complete portfolio of IAM and biometric solutions, providing local expertise, technical support, partner enablement, and deployment services across the region. BIO-key technologies offered through VaporVM include:
- PortalGuard – a comprehensive IAM platform supporting MFA, SSO, and centralized access management
- Passkey:YOU™ – a FIDO2-compliant passwordless solution
- PIN:You™ – a secure, tokenless, user-friendly PIN-based authentication method
- WEB-key – a proven biometric engine for strong authentication
- Identity-Bound Biometrics – binding access to the individual, not a device or credential
- Certified biometric scanners including PIV-Pro and EcoID III
“The collaboration combines Vapor VM’s cloud-native expertise with BIO-key’s award-winning IAM platform, PortalGuard, and biometric authentication solutions. Together, they will deliver stronger identity security, simplified access management, and compliance-driven solutions for enterprises operating across AWS, Azure, and GCP. This partnership allows us to strengthen our customers’ defenses against cyber threats while ensuring a secure and seamless digital transformation,” said Fadi Alotaibi, Regional Channel Manager at VaporVM.
“Our VaporVM partnership marks an exciting evolution in our regional strategy that builds on recent regional successes. Together, we’re bringing local expertise and world-class identity security to enterprises across the Middle East and Africa. This partnership extends our commitment to empowering customers with secure, scalable, and compliant digital transformation,” stated Nicholas Prinz, Regional Director of Middle East & Africa, BIO-key International.
“Combining our unique IAM and biometric capabilities with VaporVM’s deep regional expertise and approved vendor credentials should substantially expand our enterprise reach across the Middle East and Africa. Together, we are building a stronger cybersecurity ecosystem rooted in innovation and local collaboration,” added Alex Rocha, Managing Director, BIO-key International (EMEA).
About VAPOR VM (www.vaporvm.com)
VaporVM is a global technology and consulting company specializing in cloud transformation, cybersecurity, data analytics, and managed services. With a strong presence across the Middle East, Europe, and North America, VaporVM helps enterprises accelerate innovation and strengthen resilience through modern, secure, and scalable IT solutions.
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements, whether as a result of new information, future events, or otherwise.
| Engage with BIO-key Corporate | ||
| Facebook: | https://www.facebook.com/BIOkeyInternational/ | |
| LinkedIn: | https://www.linkedin.com/company/bio-key-international | |
| X: | @BIOkeyIntl | |
| Investors | ||
| X: | @BIO_keyIR | |
| StockTwits: | @BIO_keyIR | |
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800
FAQ
What did BIO-key (BKYI) announce on November 12, 2025?
Which BIO-key products will VaporVM promote for BKYI customers in MEA?
How will the BIO-key and VaporVM partnership affect BKYI deployment options?
Which customer types will BIO-key (BKYI) target via the VaporVM partnership?
Who are the BIO-key and VaporVM regional leaders quoted in the announcement?
